Condition
T-cell Lymphoblastic Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 T-cell Lymphoblastic Lymphoma clinical trials that are recruiting, at sites in 3 countries (most in United States (2), United Kingdom (1), China (1)). By phase: Phase 2 (1), Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest T-cell Lymphoblastic Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Anti-CCR9 CAR T-cell therapy for T‑cell acute lymphoblastic leukaemia and lymphoblastic lymphoma | Phase 1 | London | Recruiting | Dec 24, 2025 |
| Calaspargase pegol, decitabine, and venetoclax combination for relapsed/refractory T-cell ALL and T-LLy in children and young adults | Phase 2 | Houston, Texas | Recruiting | Aug 19, 2024 |
| Text messages to help sticking with oral chemotherapy in ALL and T-cell lymphoma | — | Chicago, Illinois | Recruiting | Jun 6, 2024 |
| Comparing two methotrexate treatments for children with T-cell lymphoblastic lymphoma | Phase 3 | Shanghai, Shanghai Municipality and 1 other locations | Recruiting | Jan 12, 2023 |
All recruiting trials (4)
-
Anti-CCR9 CAR T-cell therapy for T‑cell acute lymphoblastic leukaemia and lymphoblastic lymphoma
We will try anti-CCR9 CAR T cells made from your own blood to find a dose that is safe for children and adults with relapsed or refractory T‑cell leukaemia or lymphoma.
-
Calaspargase pegol, decitabine, and venetoclax combination for relapsed/refractory T-cell ALL and T-LLy in children and young adults
This treatment tries to see if giving calaspargase pegol and decitabine together with venetoclax can control relapsed or refractory T-ALL and T-LLy in children and young adults.
-
Text messages to help sticking with oral chemotherapy in ALL and T-cell lymphoma
Researchers are testing whether sending high‑frequency text reminders helps teens and adults on oral mercaptopurine and methotrexate stick with their treatment.
-
Comparing two methotrexate treatments for children with T-cell lymphoblastic lymphoma
This study tests which of two methotrexate treatments works better for children with T-cell lymphoblastic lymphoma to help them stay healthy and improve their chances of recovery.
Related topics
Quick answers
How many T-cell Lymphoblastic Lymphoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), United Kingdom (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.